Medication info

Samsung Acyclovir Tablet

Prescription medicationTabletIntravenous injectionExpired
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Samsung Pharmaceutical Co., Ltd.
Appearance
Light blue round tablets
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Expired

MFDS item code 201901353 · Approved 2019.03.06

This product's status changed to Expired on 2024.03.06. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment and prevention of herpes simplex (e.g., genital herpes); treatment of herpes zoster and varicella
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. For severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. For recurrent infections, treatment should preferably begin at the first appearance of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily after confirming efficacy. 3) To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment begins, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, for example, by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, for patients with severe renal impairment (creatinine clearance less than 10 mL per minute), this medicine should preferably be administered at 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, the dose should preferably be reduced to 800 mg per dose twice daily, approximately 12 hours apart. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, the dose should preferably be reduced to 800 mg per dose 3 times daily, approximately 8 hours apart.
Child administration
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years or older: Use the adult dosage. 2) Under 2 years: Administer 1/2 of the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years or older: Administer 20 mg per dose per kg of body weight (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should begin as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Ingredients

Manufacturer
Samsung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex (e.g., genital herpes); treatment of herpes zoster and varicella

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infections
  • shingles virus infections
  • acute pain
  • chickenpox
View approved original text

This medication is used for the treatment and prevention of herpes simplex virus infections, including primary and recurrent genital herpes. It is also effective in the treatment of shingles virus infections, particularly in alleviating acute pain. However, the effectiveness for post-herpetic neuralgia has not been sufficiently confirmed. Additionally, it is used for the treatment of chickenpox in children over 2 years old. It is effective for treating various viral infections.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. For severe initial infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. For recurrent infections, treatment should preferably begin at the first appearance of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily after confirming efficacy. 3) To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per dose, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment begins, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; use caution, for example, by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, for patients with severe renal impairment (creatinine clearance less than 10 mL per minute), this medicine should preferably be administered at 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, the dose should preferably be reduced to 800 mg per dose twice daily, approximately 12 hours apart. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, the dose should preferably be reduced to 800 mg per dose 3 times daily, approximately 8 hours apart.

Child administration

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years or older: Use the adult dosage. 2) Under 2 years: Administer 1/2 of the adult dose. 3) There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years or older: Administer 20 mg per dose per kg of body weight (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should begin as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Precautions

This medication should not be used by individuals who have had an allergic reaction to this drug or its ingredients, or to valacyclovir. Patients with impaired renal function may be more prone to neuropsychiatric side effects when using this medication, requiring caution. Patients with decreased liver function should use this drug cautiously as it may further worsen liver function. Particular care should be taken when administering this medication to infants and children, and it should only be used in the minimum necessary amounts. Elderly patients may have reduced kidney function, leading to higher blood concentrations of this medication, which may result in more frequent adverse reactions. Dosage and intervals should be adjusted accordingly for safe use. Rarely, serious allergic reactions such as anaphylaxis shock may occur while taking this medication, so if symptoms like hypotension, difficulty breathing, or chest tightness arise, administration should be stopped immediately and appropriate medical treatment should be sought. If photosensitivity reactions, skin rashes, fever, blisters, or hives occur, stop taking this medication and consult a doctor. Skin-related side effects may include hair loss, erythema multiforme, and in severe cases, Stevens-Johnson syndrome or toxic epidermal necrolysis; any unusual symptoms should be reported immediately. Neuropsychiatric side effects may present as altered consciousness, confusion, hallucinations, seizures, drowsiness, anxiety, and various other symptoms, particularly in the elderly or patients with impaired kidney function. Renal side effects may include acute kidney injury, hematuria, and proteinuria, so monitoring renal function periodically is advised. Blood and lymphatic disorders such as leukopenia, bleeding, and anemia may occur, and any unusual symptoms should be discussed with a doctor. Liver function abnormalities or jaundice, hepatitis symptoms may appear, so regular liver function tests are necessary. Gastrointestinal side effects such as gastritis, nausea, vomiting, diarrhea, and abdominal pain may occur. If symptoms are severe, discontinue use and follow medical advice. It is essential to maintain enough hydration while taking this medication to prevent dehydration and reduce the risk of renal toxicity. This medication is most effective when taken early in the onset of symptoms, and it should be started as soon as possible after the appearance of shingles or chickenpox symptoms. Immunocompromised patients may consider using intravenous formulations. This medication may lead to altered consciousness; therefore, caution is needed when driving or operating dangerous machinery, especially in patients with impaired kidney function. There may be interactions with other medications, particularly when taken with probenecid, cimetidine, theophylline, or mycophenolate mofetil; consult a doctor or pharmacist in such cases. Women who are pregnant or may become pregnant should only use this medication when the benefits outweigh the risks, and during breastfeeding, as it may be passed into breast milk, breastfeeding should be discontinued. Safety has not been established for infants and children, so it should be administered cautiously only when absolutely necessary. Elderly individuals may experience elevated blood concentrations of this medication due to reduced kidney function, so dosage and intervals should be adjusted, and adequate hydration is necessary. In cases of overdose, serious symptoms such as agitation, coma, seizures, and drowsiness may occur, requiring immediate medical assistance, and blood dialysis may be necessary if needed.

Side effects

  • anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • respiratory distress
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • blisters
Show 118 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration disturbance
  • aggressive behavior
  • depersonalization
  • agitation
  • akinesia
  • stupor
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • excitement
  • forgetfulness
  • insomnia
  • anxiety
  • verbal disinhibition
  • abnormal sensations
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • lymphocytic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • neutropenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • soft stools
  • epigastric pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • anorexia
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • malaise
  • general fatigue
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glucosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • hypoproteinemia
  • elevated total cholesterol
  • elevated triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • agitation
  • stupor
  • seizures
  • lethargy
  • confusion
  • hallucinations
  • excitement
  • epileptic seizures
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is essential to maintain a storage temperature between 1 to 30 degrees Celsius to preserve its efficacy.

Appearance and packaging

Appearance

Light blue round tablets

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.